News and developments
Bär & Karrer Advises Swedish Orphan Biovitrum AB in the Acquisition of emapalumab
Bär & Karrer acted as legal advisor to Swedish Orphan Biovitrum AB (publ). The team included Urs Brügger, Marc Poltéra, Raphael Wyss, Eliane Albert and Michael Neumann (all M&A and Corporate), Markus Schott (Regulatory), Laura Widmer (Employment), Jonas Bornhauser (IP) as well as Mani Reinert (Competition Law).